We develop a deep learning framework (DeepAccNet) that estimates per-residue accuracy and residue-residue distance signed error in protein models and uses these predictions to guide Rosetta protein structure refinement. The network uses 3D convolutions to evaluate local atomic environments followed by 2D convolutions to provide their global contexts and outperforms other methods that similarly predict the accuracy of protein structure models. Overall accuracy predictions for X-ray and cryoEM structures in the PDB correlate with their resolution, and the network should be broadly useful for assessing the accuracy of both predicted structure models and experimentally determined structures and identifying specific regions likely to be in error. Incorporation of the accuracy predictions at multiple stages in the Rosetta refinement protocol considerably increased the accuracy of the resulting protein structure models, illustrating how deep learning can improve search for global energy minima of biomolecules.
We present the DeepProfile framework, which learns a variational autoencoder (VAE) network from thousands of publicly available gene expression samples and uses this network to encode a low-dimensional representation (LDR) to predict complex disease phenotypes. To our knowledge, DeepProfile is the first attempt to use deep learning to extract a feature representation from a vast quantity of unlabeled (i.e, lacking phenotype information) expression samples that are not incorporated into the prediction problem. We use DeepProfile to predict acute myeloid leukemia patients' in vitro responses to 160 chemotherapy drugs. We show that, when compared to the original features (i.e., expression levels) and LDRs from two commonly used dimensionality reduction methods, DeepProfile: (1) better predicts complex phenotypes, (2) better captures known functional gene groups, and (3) better reconstructs the input data. We show that DeepProfile is generalizable to other diseases and phenotypes by using it to predict ovarian cancer patients' tumor invasion patterns and breast cancer patients' disease subtypes.
The trRosetta structure prediction method employs deep learning to generate predicted residue-residue distance and orientation distributions from which 3D models are built. We sought to improve the method by incorporating as inputs (in addition to sequence information) both language model embeddings and template information weighted by sequence similarity to the target. We also developed a refinement pipeline that recombines models generated by template-free and template utilizing versions of trRosetta guided by the DeepAccNet accuracy predictor.Both benchmark tests and CASP results show that the new pipeline is a considerable improvement over the original trRosetta, and it is faster and requires less computing resources, completing the entire modeling process in a median < 3 h in CASP14. Our human group improved results with this pipeline primarily by identifying additional homologous sequences for input into the network. We also used the DeepAccNet accuracy predictor to guide Rosetta high-resolution refinement for submissions in the regular and refinement categories; although performance was quite good on a CASP relative scale, the overall improvements were rather modest in part due to missing inter-domain or inter-chain contacts.
ChIP-seq is a technique to determine binding locations of transcription factors, which remains a central challenge in molecular biology. Current practice is to use a ‘control’ dataset to remove background signals from a immunoprecipitation (IP) ‘target’ dataset. We introduce the AIControl framework, which eliminates the need to obtain a control dataset and instead identifies binding peaks by estimating the distributions of background signals from many publicly available control ChIP-seq datasets. We thereby avoid the cost of running control experiments while simultaneously increasing the accuracy of binding location identification. Specifically, AIControl can (i) estimate background signals at fine resolution, (ii) systematically weigh the most appropriate control datasets in a data-driven way, (iii) capture sources of potential biases that may be missed by one control dataset and (iv) remove the need for costly and time-consuming control experiments. We applied AIControl to 410 IP datasets in the ENCODE ChIP-seq database, using 440 control datasets from 107 cell types to impute background signal. Without using matched control datasets, AIControl identified peaks that were more enriched for putative binding sites than those identified by other popular peak callers that used a matched control dataset. We also demonstrated that our framework identifies binding sites that recover documented protein interactions more accurately.
We develop a deep learning framework (DeepAccNet) that estimates per-residue accuracy and residue-residue distance signed error in protein models and uses these predictions to guide Rosetta protein structure refinement. The network uses 3D convolutions to evaluate local atomic environments followed by 2D convolutions to provide their global contexts. The network was trained on approximately 1 million alternative local energy minima for 7,510 different proteins exhibiting a wide diversity of errors, and outperforms other methods that similarly predict the accuracy of protein structure models without template or evolutionary information. Overall accuracy predictions for X-ray and cryoEM structures in the PDB correlate with resolution, and the network should be broadly useful for assessing accuracy of both predicted structure models and experimentally determined structures, and identifying specific regions likely to be in error. Guiding protein structure refinement by incorporation of the accuracy predictions at multiple stages in the Rosetta refinement protocol led to improvements in model quality in 63 out of 73 test cases, illustrating how deep learning can improve search for global energy minima.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.